Max de Vere

Max de Vere is a General Partner and Founder at re.Mind Capital, an early-stage venture capital firm specializing in transformative health technologies. He established the specialized investment vehicle alongside prominent co-founders Christian Angermayer and Jan Hardorp to identify and fund emerging scientific breakthroughs. His core investment strategy primarily targets mental and neurological health innovations, encompassing new pharmaceuticals, alternative treatment modalities, brain-computer interfaces, and digital health platforms. In his capacity as a lead investor, de Vere directs capital into specialized startups operating within these complex regulatory environments. He notably executed a $2 million seed funding round for the digital therapeutics company Ksana Health in June 2021. Currently, his professional focus remains strictly centered on identifying and advancing early-stage enterprises that develop clinical and technological solutions designed to improve global brain health and human flourishing.